Four UCSF prostate cancer specialists were featured last week in broadcast interviews about new study findings on cancer screening benefits reported in the New England Journal of Medicine. Two papers with different findings were published in the March 19, 2009 issue of the NEJM. The studies were led by researchers at the Division of Cancer Prevention, National Cancer Institute (”Mortality Results from a Randomized Prostate-Cancer Screening Trial”) and Erasmus Medical Center (”Screening and Prostate-Cancer Mortality in a Randomized European Study”).
March 18, 2009—Peter Carroll, MD, MPH, director of clinical services and strategic planning for the UCSF Helen Diller Family Comprehensive Cancer Center, was interviewed in a news report on CBS-5 (KPIX-TV Ch 5). He emphasized that PSA level alone does not indicate the need for treatment and PSA along with age, family history, and ethnicity is a much more accurate and efficient way of testing.
March 19, 2009—Matthew Cooperberg, MD, and Mack Roach, MD, were interviewed for a story for KTVU-TV, offering commentary on the two NEJM studies. Dr. Roach is a member of the board of the American Cancer Society and represented ACS in the interview.
March 20, 2009 — Kirsten Greene, MD, urologic cancer surgeon at the UCSF Helen Diller Family Comprehensive Cancer Center, was a member of a panel discussing the findings on the KQED-FM program “Forum.”